Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
After hours: February 4 at 4:03:53 PM EST Loading Chart for TCRX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback